BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16699680)

  • 1. [Retinopathy in a patient with hepatitis C treated with pegylated interferon and ribavirin: case report].
    Avila MP; Freitas AM; Isaac DL; Bastos AL; Pena RV
    Arq Bras Oftalmol; 2006; 69(2):255-9. PubMed ID: 16699680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
    Kim ET; Kim LH; Lee JI; Chin HS
    Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
    Burgueño-Montañés C; Pérez-Álvarez R
    Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin.
    Novelli FJ; Przysiezny A; Rosa EL; Garcia RF; Nóbrega MJ
    Arq Bras Oftalmol; 2014; 77(3):178-81. PubMed ID: 25295906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
    Moisseiev E; Goldenberg D; Kurtz S
    Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal nerve fibre layer defects associated with cotton-wool spots in patients with interferon retinopathy.
    Hara K; Tanito M; Ohira A
    Acta Ophthalmol; 2012 Mar; 90(2):e158-60. PubMed ID: 21649866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ocular complications of hepatitis C treatment].
    Sauer A; Lenoble P; Bader P; Speeg-Schatz C; Bourcier T; Nasica X
    J Fr Ophtalmol; 2007 Sep; 30(7):e20. PubMed ID: 17878818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is screening for interferon retinopathy in hepatitis C justified?
    Cuthbertson FM; Davies M; McKibbin M
    Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
    Schulman JA; Liang C; Kooragayala LM; King J
    Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
    Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
    Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
    J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
    Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
    Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
    Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
    World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal neovascularization with interferon associated retinopathy: case report and review of literature.
    Bazarah SM; Ritenour R; Patel ST; Hirsch G; Peltekian KM; Cruess AF
    Ann Hepatol; 2006; 5(3):172-6. PubMed ID: 17060876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C: a review of diagnosis, management, and ocular complications from treatment.
    Tsolakos A; Zalatimo N
    Optometry; 2003 Aug; 74(8):517-23. PubMed ID: 12926825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
    Adams S; Ostermeier M
    Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and interferon-associated retinopathy: a case report.
    Van Wie AM
    Optometry; 2011 Dec; 82(12):739-43. PubMed ID: 22108545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-related retinopathy in a man with chronic hepatitis C].
    Viennet A; Glatre F; Bacin F
    J Fr Ophtalmol; 2009 Sep; 32(7):505-10. PubMed ID: 19592135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon dysoric retinopathy in chronic viral hepatitis C: case report and literature review].
    Naïja N; Mohsni B; Belkahla N; Maamouri N; Ben Mami N
    Rev Med Interne; 2014 Aug; 35(8):543-5. PubMed ID: 24182682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
    Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.